Skip to main content
OpenTrials

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,519 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

NCT06780111

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • UPMC Hillman Cancer Center ( Site 1904) Pittsburgh, Pennsylvania, United States
  • Liga Norte Riograndense Contra o Cancer ( Site 1301) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceicao ( Site 1300) Porto Alegre, Rio Grande do Sul, Brazil
  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 1302) São Paulo, Brazil
View all 44 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View Trial Details
Recruiting

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT05496998

Conditions
Cardiovascular Diseases, Deglutition Disorders, Digestive System Diseases, +18 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • Clinique Pasteur Toulouse, Cedex 03, France
View all 37 locations
View Trial Details
Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

NCT06710756

Conditions
Adenoma, Adnexal Diseases, Colonic Diseases, +39 more
Locations
  • University of Miami Miami, Florida, United States
  • Biogenix Miami, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
View Trial Details

Related conditions